An IMP-4-producing Acinetobacter pittii strain coproducing oxacillinases was isolated from a leg wound of a 67-year-old female patient. Identification to the species level by rpoB and gyrB sequencing and multiplex-PCR-based analysis revealed that the isolate was A. pittii. Whole-genome sequencing of this A. pittii isolate determined the presence of bla OXA-96 , bla CARB-2 , and a novel bla OXA-421 gene. The position of this novel bla OXA-421 gene was similar to that of bla OXA-51 in A. baumannii, downstream of the phosphinothricin N-acetyltransferase gene and upstream of fxsA in the chromosome. This A. pittii isolate was found to belong to sequence type 119 (ST119). Here, we report the first isolation of IMP-4-producing A. pittii ST119 with a novel bla OXA-421 gene from a patient in Australia and characterize its draft genome.
A 67-year-old diabetic woman suffered a fall leading to a displaced distal spiral tibial plateau fracture. In the weeks prior to the fall, she had received multiple antimicrobials (clindamycin, lincomycin, cephalexin, ciprofloxacin, and ceftazidime) for an infected hematoma of the breast and a series of lower respiratory tract infections. The patient underwent definitive repair of the fracture but postoperatively developed osteomyelitis. Debridement of the leg wound was performed. Acinetobacter species and vancomycin-resistant Enterococcus strains were isolated from the tissue removed. This Acinetobacter species (CR12-42) was carbapenem resistant. Despite ongoing antibiotic treatment, the patient's leg required amputation in March 2013, after continuous inflammation, infections for more than 5 months, and an episode of severe Clostridium difficile infection resulting in colectomy. The leg infection was resolved by the amputation.
The initial identification of this Acinetobacter species was done by Vitek 2. Antimicrobial susceptibility testing by Vitek 2 (bioMérieux) showed resistance to carbapenems, ceftazidime, ceftriaxone, cefepime, gentamicin, tobramycin, trimethoprimsulfamethoxazole, ticarcillin-clavulanic acid, and ciprofloxacin according to the EUCAST standard (1). The isolate was referred to our laboratory at the University of Queensland Centre for Clinical Research. The Acinetobacter isolate was identified to the species level by a gyrB multiplex PCR, which revealed that CR12-42 was Acinetobacter pittii (2) . Partial rpoB sequencing (3) confirmed that CR12-42 was A. pittii.
Phenotypic characterization to determine the class of carbapenemase was performed as previously described (4-6). The A. pittii isolate showed a metallo-␤-lactamase phenotype by producing a larger inhibition zone around carbapenem disks with EDTA than around carbapenem disks alone (Ͼ5-mm breakpoint increase in the size of the inhibition zone). The isolate also produced a positive result in the modified Hodge and Carba NP tests for carbapenemase production. MICs were determined with Etest (bioMérieux). The isolate was resistant to all of the carbapenems tested, i.e., ceftazidime, cefotaxime, cefepime, cefoxitin, ticarcillin-clavulanic acid, trimethoprim-sulfamethoxazole, and ciprofloxacin (Table 1) . Interestingly, this A. pittii isolate was susceptible to tetracycline, minocycline, colistin, and tigecycline (Table 1) .
Carbapenem resistance in Acinetobacter species is commonly associated with the presence of carbapenem-hydrolyzing class D ␤-lactamase-or oxacillinase-encoding genes such as bla and bla in Acinetobacter baumannii (7, 8) . A PCR assay and sequencing for all of the bla OXA genes frequently present in Acinetobacter species, i.e., bla OXA-23-like , bla OXA-51-like , bla OXA-40-like , and bla OXA-58-like , were performed (7-9). The isolate was positive for the bla OXA-58-like subclass and negative for other subclasses of bla OXA . A PCR assay for ISAba1, the common insertion element in A. baumannii, was also negative. A PCR assay and sequencing for other carbapenemase-encoding genes (10, 11), i.e., bla IMP , bla NDM , bla KPC , and bla VIM , were positive for bla . A prepared pair-ended library of the whole genomic DNA was sequenced via Illumina MiSeq to further characterize the resistance mechanisms of A. pittii CR12-42 and to analyze its genome.
Whole-genome DNA sequencing produced a total of 138,932,382 paired-end reads with 30ϫ average coverage. We used the CLC genomic workbench version 7.5 (CLC Bio, Aarhus, Denmark) for de novo assembly with a 500-bp minimum threshold resulting in 127 contigs. The draft genome consisted of 4,372,178 nucleotides and was annotated by rapid annotations using subsystems technology (RAST) (12) . RAST annotation showed that Acinetobacter calcoaceticus PHEA-2 (score, 503) and Acinetobacter sp. strain SH024 (score, 436) are the two closest neighbors of A. pittii CR12-42. Our isolate was related to only one other A. pittii strain, TG6411, but with a lower score of 221. A total of 13 A. pittii draft genomes have been described in the BioProject (http://www.ncbi.nlm.nih.gov/bioproject/); however, draft ge-nomes of only three isolates were published, including one draft genome of an NDM-1-producing A. pittii strain from China (13) .
In silico identification of CR12-42 to the species level by using rpoB and gyrB showed it to be 100% identical to A. pittii. A. pittii belongs, together with Acinetobacter nosocomialis, within the A. calcoaceticus-baumannii complex and was formerly named Acinetobacter genomic species 3 (14) . In silico analysis of A. baumannii multilocus sequence typing (MLST) by the Pasteur scheme (http://www.pasteur.fr/recherche/genopole/PF8/mlst /Abaumannii.html) identified A. pittii CR12-42 as being of sequence type 119 (ST119). The alleles found were cpn-60 (n ϭ 36), fusA (n ϭ 20), gltA (n ϭ 38), pyrG (n ϭ 16), recA (n ϭ 38), rplB (n ϭ 18), and rpoB (n ϭ 20). It has been reported that MLST by the Pasteur scheme is capable of providing the ST of A. pittii (15) . The clinical significance of A. pittii ST119 is indicated by the fact that it has been reported to be the predominant clone among the A. pittii strains (18 out of 25) isolated in four hospitals in Japan (16) . Interestingly, these Japanese A. pittii isolates possessed a different bla IMP variant, bla (16) . Of note, A. pittii ST119 has not been reported previously in Australia.
The resistance genes were screened with ResFinder (17) . The ␤-lactamase-encoding genes bla IMP-4 , bla OXA-96 , and bla CARB-2 were identified. bla OXA-96 has a single nucleotide difference (a guanine-for-adenine substitution at position 483) from bla . bla OXA-96 had been reported within an A. baumannii isolate from Singapore that also harbored bla OXA-23 and bla OXA-64 (18) . In our isolate, bla OXA-96 had a genetic context similar to that of bla OXA-58 , which was bracketed by ISAba3 (GenBank accession number JX968506) (Fig. 1) .
In addition, a novel bla OXA gene, bla OXA-421 , was identified ( Fig. 1) . This gene had a genetic environment identical to that of the chromosomal bla OXA-51 gene in A. baumannii (19) , which includes two genes that are usually present upstream and downstream of bla OXA-51 in A. baumannii, the phosphinothricin Nacetyltransferase-encoding gene and fxsA, respectively. bla has 95% identity with the previously reported bla OXA gene (GenBank accession number CP002177, locus tag BDGL_000903) from the genome of A. calcoaceticus PHEA-2 (20) , which is the closest neighbor of our CR12-42 isolate, as previously mentioned. The second closest relative of bla OXA-421 was bla OXA of Acinetobacter oleivorans, with 89% similarity (GenBank accession number CP002080, locus tag AOLE_1170) (21) . The other bla OXA genes similar to bla OXA-421 were bla OXA-324 , bla OXA-325 , bla OXA-326 , bla OXA-332 , and bla OXA-354 (88 to 89% similarity), which were recently identified in A. calcoaceticus (22) . The carbapenemase activity of OXA-421 warrants further investigation.
The bla IMP-4 gene in A. pittii CR12-42 was located inside a class 1 integron. Downstream from bla IMP-4 were qacG2 and the aminoglycoside and chloramphenicol resistance genes aacA4 and catB2 (Fig. 1) . This genetic context of bla IMP-4 in CR12-42 was found to be identical to that in an IMP-4-producing A. baumannii strain from Singapore (GenBank accession number DQ532122) (18) . in an E. cloacae strain from Australia (24, 25) . However, the plasmid backbone of these sequences could not be identified within our draft genome. Further investigation is needed to determine if bla IMP-4 is located on a plasmid or the chromosome of CR12-42. A carbenicillinase gene, bla CARB-2 was identified with ResFinder. bla CARB-2 , which was also designated bla PSE-1 , was first reported in Pseudomonas aeruginosa (26) . The genetic context of bla CARB-2 in CR12-42 was also potentially a class 1 integron with a truncated integrase (intI1) located upstream of bla CARB-2 ( Fig. 1) . Other resistance genes found in this strain included sul1 (sulfonamide resistance), msr(E) and mph(E) (macrolide resistance), and aac-3-IId (aminoglycoside resistance). Consistent with this, the A. pittii strain was resistant to gentamicin and tobramycin but susceptible to amikacin. Of note, no 16S rRNA methylase was found in this isolate.
Regardless of its resistance to multiple antimicrobials, A. pittii CR12-42 remained susceptible to tetracycline and minocycline, which was consistent with the absence of a tetracycline resistance gene within the draft genome. In addition, the MIC of ampicillinsulbactam remained low (2 mg/liter), despite the presence of multiple carbapenemase-encoding genes. Further, sulbactam is known to have activity against A. baumannii (27) . In a study by Higgins et al., the ampicillin-sulbactam MIC 50 of 115 A. baumannii strains was 2 mg/liter (27) . Ampicillin-sulbactam susceptibility was also shown in the majority of the previously reported A. pittii ST119 strains harboring bla IMP-19 (94%) in Japan (16) . In addition, 94% of these were susceptible to minocycline, similar to the antimicrobial phenotype of CR12-42 (16) . Apart from the difference in bla IMP variants, CR12-42 has an antimicrobial phenotype and genotype identical to those of A. pittii ST119 from Japan.
IMP-producing Enterobacteriaceae strains have been frequently reported in Australia. Although OXA-23-like is the main subclass of carbapenemases identified in A. baumannii, IMP-4 is occasionally identified in A. pittii in locations such as Hong Kong and Singapore (18, 28) . Other variants of bla IMP , such as bla IMP-1 , bla IMP-8 , bla , and bla IMP-19 , have been described in A. pittii in Southeast Asia (16, 29, 30) . A. pittii has also recently been reported to produce NDM (31, 32) .
Generally, A. baumannii is considered the most important and the most prevalent Acinetobacter species causing infections. However, A. pittii has caused hospital outbreaks in The Netherland and China (32, 33) and was reported as the most common Acinetobacter species causing nosocomial infections in Germany (34) . Our study illustrates the emergence of a multidrug-resistant A. pittii strain in Australia. Therefore, accurate identification to the species level and characterization of the prevalence of A. pittii among the Acinetobacter species isolated in our region and its antibiotic resistance warrant further investigation.
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